Could At-Home paracentesis ease cancer belly swelling?
NCT ID NCT07490626
First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 5 times
Summary
This pilot study will test whether having a paracentesis (draining fluid from the belly) at home can improve symptoms in 20 women with cancer-related malignant ascites. Participants will have the procedure at home, and researchers will measure symptom changes using a simple survey. The study also tracks safety to see if this approach is practical and safe outside of a clinic.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- At-home paracentesis (a procedure to drain fluid from the abdomen)
- What this could lead to
- If successful, this could offer a convenient at-home option to relieve uncomfortable abdominal swelling in women with cancer-related ascites.
- What could go wrong
- This is a very small pilot study with only 20 participants, so results may not apply to everyone. There is also a risk of complications like infection or bleeding from the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2026
- Expected to finish
-
Oct 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants aged ≥ 18 years * Able to speak and understand English. * Has completed an initial clinic-based paracentesis procedure. * Confirmed diagnosis of cancer. * Symptoms related to ascites requiring procedure in the opinion of the investigator. * Eligible to receive an ultrasound-guided paracentesis procedure at home in the opinion of the investigator. * If applicable, participant is able to safely hold anticoagulant therapy per institutional standards prior to the procedure in the opinion of the investigator. * For participants of child-bearing potential, participant is following standard of care guidelines for contraception. * Able to provide informed consent and willing to sign an approved consent form that conforms to federal and institutional guidelines. Exclusion Criteria: * Rapidly deteriorating condition or suspected bowel obstruction. * Large ventral hernias or prior complications from paracentesis. * Need for concurrent procedures requiring hospital resources. * Known lack of safe environment or inability to obtain sterile conditions at home. * Any condition that would, in the Investigator's judgment, contraindicate the participant's participation in the procedure or clinical study due to safety concerns or compliance with clinical study procedures. For example, * Medical, psychiatric, cognitive, or other conditions that may compromise the participant's ability to understand the participant information, give informed consent, comply with the study protocol or complete the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Malignant ascites are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Huntsman Cancer Institute at the University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood vessel blocker stop Cancer-Related belly fluid?
- Can a Double-Targeted cell therapy outsmart Cancer's hideouts?
- Engineered immune cells take on Hard-to-Treat cancers
- New drug M701 aims to stop Cancer-Related fluid buildup without drains
- Experimental shot takes aim at stomach cancer spread
- New injection targets cancer fluid in lungs and belly